FDA Inspection 611523 — AstraZeneca Pharmaceuticals, LP
The FDA completed an inspection of AstraZeneca Pharmaceuticals, LP on September 10, 2009 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 10, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Newark, DE (United States)